A randomized, double-blind, placebo-controlled study to determine the safety and immune effects of multiple doses of vitamin D3 in patients with allergic rhinitis/rhino-conjunctivitis caused by birch pollen and in healthy control subjects.
Phase of Trial: Phase II
Latest Information Update: 07 Dec 2015
At a glance
- Drugs Paricalcitol (Primary)
- Indications Allergic rhinitis
- Focus Pharmacodynamics
- 26 Nov 2015 New trial record